Baseline hemoglobin A1c and risk of statin-induced diabetes: results of Veterans Affairs Database analysis

BMJ Open Diabetes Res Care. 2022 Jan;10(1):e002554. doi: 10.1136/bmjdrc-2021-002554.

Authors

Anna P Ziganshina¹, Darren E Gemoets², Laurence S Kaminsky², Aidar R Gosmanov^{3

4}

Affiliations

¹ Division of Endocrinology, Albany Medical College, Albany, New York, USA.
² Research and Development, Stratton VA Medical Center, Albany, New York, USA.
³ Division of Endocrinology, Albany Medical College, Albany, New York, USA agosmanov@gmail.com.
⁴ Endocrinology Section, Stratton VA Medical Center, Albany, New York, USA.

No abstract available

Keywords: atorvastatin; diabetes mellitus; glycated hemoglobin; prediabetes; type 2.

Publication types

Letter

MeSH terms

Diabetes Mellitus, Type 2* / chemically induced
Diabetes Mellitus, Type 2* / epidemiology
Glycated Hemoglobin / analysis
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
Hypoglycemic Agents
Veterans*

Substances

Glycated Hemoglobin A
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents